Compare ELTX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTX | IDN |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.2M | 73.5M |
| IPO Year | 2014 | 2014 |
| Metric | ELTX | IDN |
|---|---|---|
| Price | $3.04 | $2.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $18.00 | $7.33 |
| AVG Volume (30 Days) | 269.9K | ★ 428.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 39.29 | ★ 220.00 |
| EPS | N/A | ★ 0.06 |
| Revenue | $2,301,000.00 | ★ $4,433,454.00 |
| Revenue This Year | N/A | $12.54 |
| Revenue Next Year | N/A | $15.32 |
| P/E Ratio | ★ N/A | $51.00 |
| Revenue Growth | N/A | ★ 23.21 |
| 52 Week Low | $2.66 | $2.70 |
| 52 Week High | $16.00 | $9.08 |
| Indicator | ELTX | IDN |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 30.43 |
| Support Level | $2.72 | N/A |
| Resistance Level | $3.28 | $4.49 |
| Average True Range (ATR) | 0.17 | 0.19 |
| MACD | 0.12 | -0.07 |
| Stochastic Oscillator | 51.24 | 22.05 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.